Make Sure Patients on Sublocade Have an Active Order in the EHR

Sublocade (SUB-loh-kayd) will be the first monthly buprenorphine injection for patients with opioid use disorder.

It's a subcutaneous depot injection given in the abdomen for patients stable on 8 to 24 mg/day of buccal or sublingual buprenorphine.

But it's different from Probuphine, the 6-month implant that's only for patients on up to 8 mg/day of buprenorphine.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals